Erythropoetin treatment significantly alters measured glycated haemoglobin (HbA1c)

Diabetic Medicine

Volumn 25, Issue 2, 2008, Pages 239-240

  Ng, J M ^a   Jennings, P E ^a   Laboi, P ^a   Jayagopal, V ^a  

^a YORK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN A1C; IRON;

ADULT; AGED; ANEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GLOMERULUS FILTRATION; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY; LETTER; MALE; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; ERYTHROPOIETIN; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 39749113232     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02336.x     Document Type: Letter

References (2)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 : 837 853.
2. 1c. Clin Diabetes 2007 25 : 43 49.